CA2090701A1 - Solubilisation de proteines sous des formes actives - Google Patents

Solubilisation de proteines sous des formes actives

Info

Publication number
CA2090701A1
CA2090701A1 CA2090701A CA2090701A CA2090701A1 CA 2090701 A1 CA2090701 A1 CA 2090701A1 CA 2090701 A CA2090701 A CA 2090701A CA 2090701 A CA2090701 A CA 2090701A CA 2090701 A1 CA2090701 A1 CA 2090701A1
Authority
CA
Canada
Prior art keywords
protein
solubilization
proteins
active forms
refolding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2090701A
Other languages
English (en)
Other versions
CA2090701C (fr
Inventor
Enzo Crivelli
Nirdosh K. Puri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NATINCO NV
Original Assignee
Southern Cross Biotech Pty. Ltd.
Natinco Nv
Enzo Crivelli
Nirdosh K. Puri
Bunge (Australia) Pty. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Southern Cross Biotech Pty. Ltd., Natinco Nv, Enzo Crivelli, Nirdosh K. Puri, Bunge (Australia) Pty. Ltd. filed Critical Southern Cross Biotech Pty. Ltd.
Publication of CA2090701A1 publication Critical patent/CA2090701A1/fr
Application granted granted Critical
Publication of CA2090701C publication Critical patent/CA2090701C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Procédé de préparation d'une protéine sous une forme physiologiquement active, ledit procédé comprenant l'utilisation d'une source de protéine sous une forme au moins partiellement solubilisée; et d'un agent de réplication comprenant une quantité efficace d'un monothiol de faible masse moléculaire ou d'un dérivé de ce dernier. Dans ce procédé, on soumet la protéine solubilisée à une étape de réplication, en présence de l'agent de réplication.
CA002090701A 1990-09-05 1991-08-29 Solubilisation de proteines sous des formes actives Expired - Fee Related CA2090701C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPK2159 1990-09-05
AUPK215990 1990-09-05
PCT/AU1991/000395 WO1992004382A1 (fr) 1990-09-05 1991-08-29 Solubilisation de proteines sous des formes actives

Publications (2)

Publication Number Publication Date
CA2090701A1 true CA2090701A1 (fr) 1992-03-10
CA2090701C CA2090701C (fr) 2000-05-16

Family

ID=3774938

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002090701A Expired - Fee Related CA2090701C (fr) 1990-09-05 1991-08-29 Solubilisation de proteines sous des formes actives

Country Status (8)

Country Link
EP (1) EP0547102B1 (fr)
AT (1) ATE168115T1 (fr)
AU (1) AU664021B2 (fr)
CA (1) CA2090701C (fr)
DE (1) DE69129747T2 (fr)
DK (1) DK0547102T3 (fr)
ES (1) ES2119779T3 (fr)
WO (1) WO1992004382A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4665193A (en) * 1992-07-02 1994-01-31 Pitman-Moore, Inc. A process for recovering a recombinant protein, in biologically active form, from a solution containing inactive protein
DK44593D0 (da) * 1993-04-20 1993-04-20 Novo Nordisk As Fremgangsmaade til fremstilling af et polypeptid
CN1057775C (zh) * 1993-09-22 2000-10-25 味之素株式会社 具有抗血栓活性的肽及其制法
ZA955789B (en) * 1994-07-15 1996-03-11 Novo Nordisk As A method of converting a hydrophobic derivative of a polypeptide into the native form
DE10309691B4 (de) * 2003-02-28 2018-10-04 Hans-Knöll-Institut für Naturstoff-Forschung e.V. Gewinnung von löslichen Proteinen aus der Biomasse rekombinanter Mikroorganismen
BRPI1011940B8 (pt) 2009-06-22 2021-08-03 Amgen Inc método de redobramento de uma proteína expressa em um sistema de expressão de não mamífero
EP2445924B2 (fr) 2009-06-25 2023-12-13 Amgen Inc. Procédés de purification par capture de protéines exprimées dans un système non mammifère
EP3617220B1 (fr) 2013-02-12 2021-03-24 Bristol-Myers Squibb Company Procédés de repliement de protéine à ph élevé
EP2956468B1 (fr) 2013-02-12 2020-06-10 Bristol-Myers Squibb Company Procédés de repliement de protéine utilisant la filtration tangentielle
EP2978770B1 (fr) 2013-03-29 2019-11-06 Dr. Reddy's Laboratories Limited Repliement de protéines
US10745457B2 (en) 2015-09-02 2020-08-18 Merck Sharp & Dohme Corp. Process for obtaining insulin with correctly formed disulfide bonds

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6079000A (ja) * 1983-10-04 1985-05-04 Takeda Chem Ind Ltd ヒトγ型インタ−フエロン単量体の製造法
ATE92935T1 (de) * 1984-12-06 1993-08-15 Synergen Biolog Inc Serinproteaseinhibitoren und isolierungsverfahren dazu.
DE3537708A1 (de) * 1985-10-23 1987-04-23 Boehringer Mannheim Gmbh Verfahren zur aktivierung von t-pa nach expression in prokaryonten
US4766205A (en) * 1985-11-13 1988-08-23 Beatrice Companies, Inc. Method for isolation of recombinant polypeptides in biologically active forms
DE3611817A1 (de) * 1986-04-08 1987-10-15 Boehringer Mannheim Gmbh Verfahren zur renaturierung von proteinen
AU612133B2 (en) * 1987-02-20 1991-07-04 Natinco Nv Production of proteins in active forms
IL86090A (en) * 1987-04-16 1993-03-15 Cetus Oncology Corp Production of purified, biologically active, bacterially produced recombinant human csf-1
EP0295859B1 (fr) * 1987-06-15 1994-11-17 Southern Cross Biotech Pty.Ltd. Préparation de protéines dans les formes actives
WO1989001046A1 (fr) * 1987-07-29 1989-02-09 Schering Biotech Corporation Purification d'interleukine-4 humaines exprimee dans escherichia coli
CA1340586C (fr) * 1988-09-23 1999-06-08 Cetus Corporation Methode pour recuperer l'interferon beta produit par voie microbienne
DE3832898A1 (de) * 1988-09-28 1990-04-12 Boehringer Mannheim Gmbh Praeparat von in prokaryonten exprimiertem plasminogenaktivator
DE3901719A1 (de) * 1989-01-21 1990-07-26 Hoechst Ag Verfahren zur herstellung eines insulinvorlaeufers
DE3901718A1 (de) * 1989-01-21 1990-07-26 Hoechst Ag Verfahren zur renaturierung falscher rekombinanten von insulinvorlaeufern
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
US5235043A (en) * 1990-04-06 1993-08-10 Synergen, Inc. Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins
DE4113750A1 (de) * 1991-04-26 1992-10-29 Boehringer Mannheim Gmbh Verbesserung der renaturierung bei der sekretion von disulfidverbrueckten proteinen

Also Published As

Publication number Publication date
CA2090701C (fr) 2000-05-16
DK0547102T3 (da) 1999-04-19
EP0547102B1 (fr) 1998-07-08
EP0547102A4 (fr) 1994-04-27
DE69129747D1 (de) 1998-08-13
AU664021B2 (en) 1995-11-02
ATE168115T1 (de) 1998-07-15
WO1992004382A1 (fr) 1992-03-19
ES2119779T3 (es) 1998-10-16
DE69129747T2 (de) 1998-11-12
EP0547102A1 (fr) 1993-06-23
AU8403591A (en) 1992-03-30

Similar Documents

Publication Publication Date Title
NO882635D0 (no) Fremgangsmaate for fremstilling av proteiner i aktive former.
DE69529219D1 (en) Helicobacter proteine und impstoffe
DK183386A (da) Sucralfatsuspension
WO1998017319A3 (fr) Substituts de plaquettes et procedes de conjugaison appropries pour leur preparation
CA2090701A1 (fr) Solubilisation de proteines sous des formes actives
BR9709845A (pt) Preparação aquosa de insulina formulação farmacêutica parenteral e processo para aumentar a estabilidade química de uma preparação de insulina
AU1141288A (en) Production of proteins in active forms
ATE88087T1 (de) Chitosan enthaltendes kosmetisches praeparat.
DE69531793D1 (de) Immunogene zubereitungen
AU636723B2 (en) Composition for the preparation of artificial calf milk and artificial calf milk prepared therefrom
EP0456842A4 (en) Medicinal application of m-csf
FI944907A (fi) Uusi antineoplastinen sytokiini
GB2228936A (en) Rhoptry membrane antigen of plasmodium falciparum

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed